Category: In Vitro Diagnostics
Global In Vitro Diagnostics
-
Veterinary Hematology Analyzers
... at a CAGR of 5.3% over the analysis period 2024-2030. Table Top Analyzers, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$1.2 Billion by the end ... Read More
-
Blood Screening
... CAGR of 5.5% over the analysis period 2024-2030. Blood Screening Reagents & Kits, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$2.7 Billion by the end ... Read More
-
In-Vitro Colorectal Cancer Screening Tests
... Billion by 2030, growing at a CAGR of 3.3% over the analysis period 2024-2030. Fecal Occult Blood Test, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach ... Read More
-
Creatinine Assay Kits
... at a CAGR of 2.2% over the analysis period 2024-2030. Jaffe`s Kinetic Test Kits, one of the segments analyzed in the report, is expected to record a 2.1% CAGR and reach US$102.1 Million by the ... Read More
-
Dengue Testing
... CAGR of 4.8% over the analysis period 2024-2030. ELISA-Based Tests, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$383.2 Million by the end of the analysis ... Read More
-
Human Reproductive Technologies
... at a CAGR of 2.2% over the analysis period 2024-2030. Contraceptive Drugs & Devices, one of the segments analyzed in the report, is expected to record a 2.5% CAGR and reach US$22.0 Billion by the ... Read More
-
Modular Laboratory Automation
... at a CAGR of 6.5% over the analysis period 2024-2030. Automated Liquid Handlers, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$1.4 Billion by the end ... Read More
-
Hemoglobin A1c (HbA1c) Testing Global Market Report 2025
... (hba1c) testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly ... Read More
-
Drug Abuse Testing
... at a CAGR of 5.3% over the analysis period 2024-2030. Laboratory Services, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$52.0 Billion by the end of ... Read More
-
Histology and Cytology
... at a CAGR of 14.4% over the analysis period 2024-2030. Cytology, one of the segments analyzed in the report, is expected to record a 15.3% CAGR and reach US$50.6 Billion by the end of the ... Read More
-
In-Vitro Diagnostics (IVD) Packaging
... 2030, growing at a CAGR of 4.5% over the analysis period 2024-2030. Bottles, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$4.0 Billion by the end ... Read More
-
Antithrombin
... 5.3% over the analysis period 2024-2030. Therapeutics, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$847.5 Million by the end of the analysis period. Growth in ... Read More
-
Bio-MEMS
... 16.7% over the analysis period 2024-2030. Microfluidic Chips, one of the segments analyzed in the report, is expected to record a 17.1% CAGR and reach US$27.4 Billion by the end of the analysis period. Growth ... Read More
-
Biomedical Refrigerators and Freezers
... 2030, growing at a CAGR of 3.3% over the analysis period 2024-2030. Ultra Low Temperature (ULT) Freezers, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$533.2 ... Read More
-
Blood Transfusion Diagnostics
... at a CAGR of 4.7% over the analysis period 2024-2030. Instruments, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$1.7 Billion by the end of the ... Read More
-
Cervical Dysplasia Diagnostics
... at a CAGR of 5.9% over the analysis period 2024-2030. Diagnostic Tests, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$793.8 Million by the end of ... Read More
-
STD Testing
... CAGR of 5.2% over the analysis period 2024-2030. Chlamydia, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$40.6 Billion by the end of the analysis period. ... Read More
-
Anatomic Pathology
... CAGR of 5.8% over the analysis period 2024-2030. Anatomic Pathology Services, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$36.4 Billion by the end of the ... Read More
-
Blood Transfusion Devices
... at a CAGR of 5.8% over the analysis period 2024-2030. Pathogen Reduction System, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$3.7 Billion by the end ... Read More
-
Immunohematology Analyzers and Reagents
... 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Immunohematology Reagents, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$2.3 Billion by the ... Read More
-
Microfluidics
... 16.0% over the analysis period 2024-2030. Devices, one of the segments analyzed in the report, is expected to record a 14.4% CAGR and reach US$63.5 Billion by the end of the analysis period. Growth in ... Read More
-
Multiplex Assays
... CAGR of 6.4% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$3.7 Billion by the end of the analysis period. ... Read More
-
Nucleic Acid Isolation and Purification
... Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2024-2030. Kits, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$5.3 Billion by ... Read More
-
Paper Diagnostics
... CAGR of 6.6% over the analysis period 2024-2030. Lateral Flow Assay Kits, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$6.7 Billion by the end of ... Read More
-
Infectious Disease Diagnostics
... at a CAGR of 5.5% over the analysis period 2024-2030. Assays & Reagents, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$25.8 Billion by the end ... Read More
Research Assistance
